EUVIMEDEUVIMED entdecken
Leserbrief

Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions

Mauro Iannopollo

Pancreatology · 2026-08 · 26 (5) · 801-802

DOI: 10.1016/j.pan.2026.04.018 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pancreatology, 2026-08. Verfasst von Mauro Iannopollo. Beteiligte Einrichtung: Medical Oncology Unit (SOC), Azienda USL Toscana Centro, Ospedali di Pistoia e Pescia, Pistoia, Italy. Electronic address: mauro.iannopollo@uslcentro…. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Medical Oncology Unit (SOC), Azienda USL Toscana Centro, Ospedali di Pistoia e Pescia, Pistoia, Italy. Electronic address: mauro.iannopollo@uslcentro.toscana.it.

Zitieren

APA

Iannopollo, M. (2026). Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions. Pancreatology, 26(5), 801-802. https://doi.org/10.1016/j.pan.2026.04.018

Vancouver

Iannopollo M. Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions. Pancreatology. 2026;26(5):801-802. doi:10.1016/j.pan.2026.04.018

BibTeX
@article{Iannopollo2026,
  author = {Iannopollo, Mauro},
  title = {Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions},
  journal = {Pancreatology},
  year = {2026},
  volume = {26},
  number = {5},
  pages = {801--802},
  doi = {10.1016/j.pan.2026.04.018}
}
Kostenlos starten →